Form 6-K GLAXOSMITHKLINE PLC For: Feb 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
GlaxoSmithKline plc (GSK) Reports Q4 EPS of GBP0.22
February 4, 2015 7:10 AM ESTGlaxoSmithKline plc (NYSE: GSK) reported Q4 EPS of GBP0.22, versus GBP0.51 reported last year. Revenue for the quarter came in at GBP6.19 million, versus GBP6.91 million reported last year.
For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.
... More


